In vivo delivery of siRNA targeting vasohibin‐2 decreases tumor angiogenesis and suppresses tumor growth in ovarian cancer

Vasohibin‐2 (VASH2) is a homolog of vasohibin‐1 and exhibits pro‐angiogenic activity. We recently reported that VASH2 is expressed in certain ovarian cancers and promotes tumor growth through angiogenesis. To further demonstrate the effectiveness of molecular targeting of VASH2 for anticancer treatm...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Sci
Main Authors: Koyanagi, Takahiro, Suzuki, Yasuhiro, Saga, Yasushi, Machida, Shizuo, Takei, Yuji, Fujiwara, Hiroyuki, Suzuki, Mitsuaki, Sato, Yasufumi
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2013
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7654253/
https://ncbi.nlm.nih.gov/pubmed/24118388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12297
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki